Chronic disease outcomes after severe acute malnutrition in Malawian children (ChroSAM): a cohort study
Background: Tackling severe acute malnutrition (SAM) is a global health priority. Heightened risk of non-communicable diseases (NCD) in children exposed to SAM at around 2 years of age is plausible in view of previously described consequences of other early nutritional insults. By applying developme...
Main Authors: | , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2016-09-01
|
Series: | The Lancet Global Health |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2214109X16301334 |
id |
doaj-85f43094f71a4753883d39119de48b8a |
---|---|
record_format |
Article |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Dr. Natasha Lelijveld, PhD Andrew Seal, PhD Prof. Jonathan C Wells, PhD Jane Kirkby, PhD Charles Opondo, PhD Emmanuel Chimwezi, Dip James Bunn, MRCP Robert Bandsma, PhD Prof. Robert S Heyderman, PhD Prof. Moffat J Nyirenda, PhD Marko Kerac, MRCPCH |
spellingShingle |
Dr. Natasha Lelijveld, PhD Andrew Seal, PhD Prof. Jonathan C Wells, PhD Jane Kirkby, PhD Charles Opondo, PhD Emmanuel Chimwezi, Dip James Bunn, MRCP Robert Bandsma, PhD Prof. Robert S Heyderman, PhD Prof. Moffat J Nyirenda, PhD Marko Kerac, MRCPCH Chronic disease outcomes after severe acute malnutrition in Malawian children (ChroSAM): a cohort study The Lancet Global Health |
author_facet |
Dr. Natasha Lelijveld, PhD Andrew Seal, PhD Prof. Jonathan C Wells, PhD Jane Kirkby, PhD Charles Opondo, PhD Emmanuel Chimwezi, Dip James Bunn, MRCP Robert Bandsma, PhD Prof. Robert S Heyderman, PhD Prof. Moffat J Nyirenda, PhD Marko Kerac, MRCPCH |
author_sort |
Dr. Natasha Lelijveld, PhD |
title |
Chronic disease outcomes after severe acute malnutrition in Malawian children (ChroSAM): a cohort study |
title_short |
Chronic disease outcomes after severe acute malnutrition in Malawian children (ChroSAM): a cohort study |
title_full |
Chronic disease outcomes after severe acute malnutrition in Malawian children (ChroSAM): a cohort study |
title_fullStr |
Chronic disease outcomes after severe acute malnutrition in Malawian children (ChroSAM): a cohort study |
title_full_unstemmed |
Chronic disease outcomes after severe acute malnutrition in Malawian children (ChroSAM): a cohort study |
title_sort |
chronic disease outcomes after severe acute malnutrition in malawian children (chrosam): a cohort study |
publisher |
Elsevier |
series |
The Lancet Global Health |
issn |
2214-109X |
publishDate |
2016-09-01 |
description |
Background: Tackling severe acute malnutrition (SAM) is a global health priority. Heightened risk of non-communicable diseases (NCD) in children exposed to SAM at around 2 years of age is plausible in view of previously described consequences of other early nutritional insults. By applying developmental origins of health and disease (DOHaD) theory to this group, we aimed to explore the long-term effects of SAM.
Methods: We followed up 352 Malawian children (median age 9·3 years) who were still alive following SAM inpatient treatment between July 12, 2006, and March 7, 2007, (median age 24 months) and compared them with 217 sibling controls and 184 age-and-sex matched community controls. Our outcomes of interest were anthropometry, body composition, lung function, physical capacity (hand grip, step test, and physical activity), and blood markers of NCD risk. For comparisons of all outcomes, we used multivariable linear regression, adjusted for age, sex, HIV status, and socioeconomic status. We also adjusted for puberty in the body composition regression model.
Findings: Compared with controls, children who had survived SAM had lower height-for-age Z scores (adjusted difference vs community controls 0·4, 95% CI 0·6 to 0·2, p=0·001; adjusted difference vs sibling controls 0·2, 0·0 to 0·4, p=0·04), although they showed evidence of catch-up growth. These children also had shorter leg length (adjusted difference vs community controls 2·0 cm, 1·0 to 3·0, p<0·0001; adjusted difference vs sibling controls 1·4 cm, 0·5 to 2·3, p=0·002), smaller mid-upper arm circumference (adjusted difference vs community controls 5·6 mm, 1·9 to 9·4, p=0·001; adjusted difference vs sibling controls 5·7 mm, 2·3 to 9·1, p=0·02), calf circumference (adjusted difference vs community controls 0·49 cm, 0·1 to 0·9, p=0·01; adjusted difference vs sibling controls 0·62 cm, 0·2 to 1·0, p=0·001), and hip circumference (adjusted difference vs community controls 1·56 cm, 0·5 to 2·7, p=0·01; adjusted difference vs sibling controls 1·83 cm, 0·8 to 2·8, p<0·0001), and less lean mass (adjusted difference vs community controls −24·5, −43 to −5·5, p=0·01; adjusted difference vs sibling controls −11·5, −29 to −6, p=0·19) than did either sibling or community controls. Survivors of SAM had functional deficits consisting of weaker hand grip (adjusted difference vs community controls −1·7 kg, 95% CI −2·4 to −0·9, p<0·0001; adjusted difference vs sibling controls 1·01 kg, 0·3 to 1·7, p=0·005,)) and fewer minutes completed of an exercise test (sibling odds ratio [OR] 1·59, 95% CI 1·0 to 2·5, p=0·04; community OR 1·59, 95% CI 1·0 to 2·5, p=0·05). We did not detect significant differences between cases and controls in terms of lung function, lipid profile, glucose tolerance, glycated haemoglobin A1c, salivary cortisol, sitting height, and head circumference.
Interpretation: Our results suggest that SAM has long-term adverse effects. Survivors show patterns of so-called thrifty growth, which is associated with future cardiovascular and metabolic disease. The evidence of catch-up growth and largely preserved cardiometabolic and pulmonary functions suggest the potential for near-full rehabilitation. Future follow-up should try to establish the effects of puberty and later dietary or social transitions on these parameters, as well as explore how best to optimise recovery and quality of life for survivors.
Funding: The Wellcome Trust. |
url |
http://www.sciencedirect.com/science/article/pii/S2214109X16301334 |
work_keys_str_mv |
AT drnatashalelijveldphd chronicdiseaseoutcomesaftersevereacutemalnutritioninmalawianchildrenchrosamacohortstudy AT andrewsealphd chronicdiseaseoutcomesaftersevereacutemalnutritioninmalawianchildrenchrosamacohortstudy AT profjonathancwellsphd chronicdiseaseoutcomesaftersevereacutemalnutritioninmalawianchildrenchrosamacohortstudy AT janekirkbyphd chronicdiseaseoutcomesaftersevereacutemalnutritioninmalawianchildrenchrosamacohortstudy AT charlesopondophd chronicdiseaseoutcomesaftersevereacutemalnutritioninmalawianchildrenchrosamacohortstudy AT emmanuelchimwezidip chronicdiseaseoutcomesaftersevereacutemalnutritioninmalawianchildrenchrosamacohortstudy AT jamesbunnmrcp chronicdiseaseoutcomesaftersevereacutemalnutritioninmalawianchildrenchrosamacohortstudy AT robertbandsmaphd chronicdiseaseoutcomesaftersevereacutemalnutritioninmalawianchildrenchrosamacohortstudy AT profrobertsheydermanphd chronicdiseaseoutcomesaftersevereacutemalnutritioninmalawianchildrenchrosamacohortstudy AT profmoffatjnyirendaphd chronicdiseaseoutcomesaftersevereacutemalnutritioninmalawianchildrenchrosamacohortstudy AT markokeracmrcpch chronicdiseaseoutcomesaftersevereacutemalnutritioninmalawianchildrenchrosamacohortstudy |
_version_ |
1724907814974914560 |
spelling |
doaj-85f43094f71a4753883d39119de48b8a2020-11-25T02:12:51ZengElsevierThe Lancet Global Health2214-109X2016-09-0149e654e66210.1016/S2214-109X(16)30133-4Chronic disease outcomes after severe acute malnutrition in Malawian children (ChroSAM): a cohort studyDr. Natasha Lelijveld, PhD0Andrew Seal, PhD1Prof. Jonathan C Wells, PhD2Jane Kirkby, PhD3Charles Opondo, PhD4Emmanuel Chimwezi, Dip5James Bunn, MRCP6Robert Bandsma, PhD7Prof. Robert S Heyderman, PhD8Prof. Moffat J Nyirenda, PhD9Marko Kerac, MRCPCH10Institute for Global Health, University College London, London, UKInstitute for Global Health, University College London, London, UKChildhood Nutrition Research Centre, Institute of Child Health, University College London, London, UKRespiratory, Critical Care & Anaesthesia section in IIIP, Institute of Child Health, University College London, London, UKDepartment of Medical Statistics, London School of Hygiene & Tropical Medicine, London, UKMalawi-Liverpool Wellcome Trust Clinical Research Programme, University of Malawi College of Medicine, Blantyre, MalawiAlder Hey Children's NHS Foundation Trust, Liverpool, UKDepartment of Pediatrics, Division of Gastroenterology, Hepatology and Nutrition, The Hospital for Sick Children, Toronto, ON, CanadaDivision of Infection & Immunity, University College London, London, UKDepartment of Population Health, London School of Hygiene & Tropical Medicine, London, UKLeonard Cheshire Disability & Inclusive Development Centre, Department of Epidemiology & Child Health, University College London, London, UKBackground: Tackling severe acute malnutrition (SAM) is a global health priority. Heightened risk of non-communicable diseases (NCD) in children exposed to SAM at around 2 years of age is plausible in view of previously described consequences of other early nutritional insults. By applying developmental origins of health and disease (DOHaD) theory to this group, we aimed to explore the long-term effects of SAM. Methods: We followed up 352 Malawian children (median age 9·3 years) who were still alive following SAM inpatient treatment between July 12, 2006, and March 7, 2007, (median age 24 months) and compared them with 217 sibling controls and 184 age-and-sex matched community controls. Our outcomes of interest were anthropometry, body composition, lung function, physical capacity (hand grip, step test, and physical activity), and blood markers of NCD risk. For comparisons of all outcomes, we used multivariable linear regression, adjusted for age, sex, HIV status, and socioeconomic status. We also adjusted for puberty in the body composition regression model. Findings: Compared with controls, children who had survived SAM had lower height-for-age Z scores (adjusted difference vs community controls 0·4, 95% CI 0·6 to 0·2, p=0·001; adjusted difference vs sibling controls 0·2, 0·0 to 0·4, p=0·04), although they showed evidence of catch-up growth. These children also had shorter leg length (adjusted difference vs community controls 2·0 cm, 1·0 to 3·0, p<0·0001; adjusted difference vs sibling controls 1·4 cm, 0·5 to 2·3, p=0·002), smaller mid-upper arm circumference (adjusted difference vs community controls 5·6 mm, 1·9 to 9·4, p=0·001; adjusted difference vs sibling controls 5·7 mm, 2·3 to 9·1, p=0·02), calf circumference (adjusted difference vs community controls 0·49 cm, 0·1 to 0·9, p=0·01; adjusted difference vs sibling controls 0·62 cm, 0·2 to 1·0, p=0·001), and hip circumference (adjusted difference vs community controls 1·56 cm, 0·5 to 2·7, p=0·01; adjusted difference vs sibling controls 1·83 cm, 0·8 to 2·8, p<0·0001), and less lean mass (adjusted difference vs community controls −24·5, −43 to −5·5, p=0·01; adjusted difference vs sibling controls −11·5, −29 to −6, p=0·19) than did either sibling or community controls. Survivors of SAM had functional deficits consisting of weaker hand grip (adjusted difference vs community controls −1·7 kg, 95% CI −2·4 to −0·9, p<0·0001; adjusted difference vs sibling controls 1·01 kg, 0·3 to 1·7, p=0·005,)) and fewer minutes completed of an exercise test (sibling odds ratio [OR] 1·59, 95% CI 1·0 to 2·5, p=0·04; community OR 1·59, 95% CI 1·0 to 2·5, p=0·05). We did not detect significant differences between cases and controls in terms of lung function, lipid profile, glucose tolerance, glycated haemoglobin A1c, salivary cortisol, sitting height, and head circumference. Interpretation: Our results suggest that SAM has long-term adverse effects. Survivors show patterns of so-called thrifty growth, which is associated with future cardiovascular and metabolic disease. The evidence of catch-up growth and largely preserved cardiometabolic and pulmonary functions suggest the potential for near-full rehabilitation. Future follow-up should try to establish the effects of puberty and later dietary or social transitions on these parameters, as well as explore how best to optimise recovery and quality of life for survivors. Funding: The Wellcome Trust.http://www.sciencedirect.com/science/article/pii/S2214109X16301334 |